US vaccines could offset India’s export controls (World Bank President)
The World Bank president said that while vaccine shortages remain the biggest obstacle to getting people immunized in developing countries, increased production in the United States may be able to meet growing demand.
“We, the World Bank, have programs in 28 countries now and very quickly [we will have] 50 countries ready to provide the capacity to effectively deliver vaccines. But still, delivery schedules are the biggest challenge, ”David Robert Malpass told CBC News Network. Power and politics in an interview broadcast today.
Malpass said India’s decision to restrict exports of the AstraZeneca vaccine from the Serum Institute of India after a terrifying second wave began to hit the country was a major factor in the vaccine shortage in developing countries. development.
“But the good news – production runs in the United States have exceeded people’s high hopes. And so, the volumes of vaccine available are increasing. And there should be a way to balance that,” he said. told guest host David Common.
While the World Trade Organization considers a proposal to waive vaccine patents, Malpass said, the World Bank is instead supporting the licensing of vaccine patents to developing countries and financing of production.
“The part of the World Bank called the International Finance Corporation has funding and is investing in debt and equity in companies in the developing world to manufacture vaccines. And we will be making announcements on that in the next two weeks.” , did he declare.
You can watch full episodes of Power & Politics at CBC Gem, CBC’s streaming service.